hydrogen sulfide has been researched along with paclitaxel in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Fukushima, N; Kanaoka, D; Kawabata, A; Matsunami, M; Ohkubo, T; Okubo, K; Sekiguchi, F; Takahashi, T; Yamazaki, J; Yoshida, S | 1 |
| Kawabata, A | 1 |
| Babula, P; Chovancova, B; Kajsik, M; Krizanova, O; Liskova, V | 1 |
3 other study(ies) available for hydrogen sulfide and paclitaxel
| Article | Year |
|---|---|
Inhibition of T-type calcium channels and hydrogen sulfide-forming enzyme reverses paclitaxel-evoked neuropathic hyperalgesia in rats.
Topics: Animals; Antineoplastic Agents; Benzimidazoles; Blotting, Western; Calcium Channels, T-Type; Cyclopropanes; Enzyme Inhibitors; HEK293 Cells; Humans; Hydrogen Sulfide; Hyperalgesia; Male; Naphthalenes; Neuralgia; Paclitaxel; Patch-Clamp Techniques; Rats; Rats, Wistar | 2011 |
[Targeting Ca(v)3.2 T-type calcium channels as a therapeutic strategy for chemotherapy-induced neuropathic pain].
Topics: Animals; Antineoplastic Agents; Ascorbic Acid; Calcium Channels, T-Type; Dinoprostone; Humans; Hydrogen Sulfide; Molecular Targeted Therapy; Neuralgia; Paclitaxel; Peripheral Nervous System Diseases | 2013 |
Slow sulfide donor GYY4137 potentiates effect of paclitaxel on colorectal carcinoma cells.
Topics: Adenosine Triphosphate; Apoptosis; Cell Line, Tumor; Colorectal Neoplasms; Humans; Hydrogen Sulfide; Morpholines; Organothiophosphorus Compounds; Paclitaxel; Sulfides | 2022 |